Director
DIN: 08418695
Poonam Kumari is currently associated with 2 companies in various capacities such as Additional Director, Director and Individual Promoter. They serve as a Director at SPECIAL LIFE PHARMACEUTICALS PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 08418695.Poonam Kumari is currently involved in 3 different roles. Their most recent position is with RASY RAYS CONSTRUCTION PRIVATE LIMITED as a Director. The first company Poonam Kumari was appointed to as a director was SPECIAL LIFE PHARMACEUTICALS PRIVATE LIMITED. Poonam Kumari is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Poonam Kumari is currently associated with 2 companies in various capacities such as Additional Director, Director and Individual Promoter. They serve as a Director at SPECIAL LIFE PHARMACEUTICALS PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 08418695.Poonam Kumari is currently involved in 3 different roles. Their most recent position is with RASY RAYS CONSTRUCTION PRIVATE LIMITED as a Director. The first company Poonam Kumari was appointed to as a director was SPECIAL LIFE PHARMACEUTICALS PRIVATE LIMITED. Poonam Kumari is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
3
Female
India
Call +91 81049 46419 and we'll pull the verified contact details for you.
Current Companies (2)
Current LLPs (0)
Past Companies (0)
1y 6m 9 Months Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| SPECIAL LIFE PHARMACEUTICALS PRIVATE LIMITED | Additional Director | 07-Mar-2019 |
| RASY RAYS CONSTRUCTION PRIVATE LIMITED | Director | 17-Jun-2022 |
| RASY RAYS CONSTRUCTION PRIVATE LIMITED | Individual Promoter | 17-Jun-2022 |